Margaret M. FitzPatrick - 28 May 2025 Form 4 Insider Report for AN2 Therapeutics, Inc. (ANTX)

Role: Director
Signature: /s/ Lucy Day, Attorney-in-Fact for Margaret M. FitzPatrick
Issuer symbol: ANTX
Transactions as of: 28 May 2025
Transactions value $: $10,133
Form type: 4
Filing time: 29 May 2025, 16:17:48 UTC
Previous filing: 23 May 2025
Next filing: 11 Sep 2025
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
FitzPatrick Margaret M	Director	C/O AN2 THERAPEUTICS, INC., 1800 EL CAMINO REAL, SUITE D, MENLO PARK	/s/ Lucy Day, Attorney-in-Fact for Margaret M. FitzPatrick	29 May 2025	0001873879

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ANTX	Common Stock	Purchase	$10.1K	+8.61K		$1.18	8.61K	28 May 2025	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	This price represents the weighted average purchase price for multiple transactions reported on this line. The prices of the transactions reported on this line ranged from $1.17 to $1.18 per share. Upon request by the Commission staff, the issuer or a security holder of the issuer, the reporting person will undertake to provide full information regarding the number of shares sold at each separate price.

Content

This price represents the weighted average purchase price for multiple transactions reported on this line. The prices of the transactions reported on this line ranged from $1.17 to $1.18 per share. Upon request by the Commission staff, the issuer or a security holder of the issuer, the reporting person will undertake to provide full information regarding the number of shares sold at each separate price.